Detalhe da pesquisa
1.
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.
Arthritis Rheumatol
; 71(3): 451-459, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30225949
2.
High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.
Arthritis Rheumatol
; 70(4): 594-605, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29287303
3.
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Arthritis Rheumatol
; 70(9): 1508-1518, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29604189
4.
Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.
Clin Rheumatol
; 36(2): 351-359, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28013435
5.
Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
J Rheumatol
; 44(12): 1884-1888, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28811355
6.
Improving Pneumococcal Vaccination in Pediatric Rheumatology Patients.
Pediatrics
; 136(3): e681-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26304825
7.
Juvenile idiopathic arthritis: an update.
WMJ
; 102(7): 45-50, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14711024
8.
Minimal clinically important differences of disease activity indices in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken)
; 62(7): 950-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20589695
9.
Prospective validation of the provisional criteria for the evaluation of response to therapy in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken)
; 62(3): 335-44, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20391479
10.
Toward the development of criteria for global flares in juvenile systemic lupus erythematosus.
Arthritis Care Res (Hoboken)
; 62(6): 811-20, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20535792
11.
Health-related quality of life and its relationship to patient disease course in childhood-onset systemic lupus erythematosus.
J Rheumatol
; 36(7): 1536-45, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19487266
12.
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
Arthritis Rheum
; 60(7): 2113-23, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19565504
13.
Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis.
Arthritis Rheum
; 60(7): 2102-12, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19565513
14.
Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.
Arthritis Rheum
; 48(1): 218-26, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12528122